Your browser doesn't support javascript.
loading
Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives.
Bauckneht, Matteo; Ciccarese, Chiara; Laudicella, Riccardo; Mosillo, Claudia; D'Amico, Francesca; Anghelone, Annunziato; Strusi, Alessandro; Beccia, Viria; Bracarda, Sergio; Fornarini, Giuseppe; Tortora, Giampaolo; Iacovelli, Roberto.
Afiliação
  • Bauckneht M; Nuclear Medicine, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Health Sciences (DISSAL), University of Genova, Genova, Italy. Electronic address: matteo.bauckneht@unige.it.
  • Ciccarese C; Medical Oncology, Fondazione Policlinico A. Gemelli IRCCS, Largo Agostino Gemelli 8, 00168 Rome, Italy.
  • Laudicella R; Nuclear Medicine Unit, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, 98124 Messina, Italy.
  • Mosillo C; Oncologia Medica e Traslazionale, Azienda Ospedaliera Santa Maria di Terni, Terni, Italy.
  • D'Amico F; Department of Health Sciences (DISSAL), University of Genova, Genova, Italy.
  • Anghelone A; Medical Oncology, Fondazione Policlinico A. Gemelli IRCCS, Largo Agostino Gemelli 8, 00168 Rome, Italy.
  • Strusi A; Medical Oncology, Fondazione Policlinico A. Gemelli IRCCS, Largo Agostino Gemelli 8, 00168 Rome, Italy.
  • Beccia V; Medical Oncology, Fondazione Policlinico A. Gemelli IRCCS, Largo Agostino Gemelli 8, 00168 Rome, Italy.
  • Bracarda S; Oncologia Medica e Traslazionale, Azienda Ospedaliera Santa Maria di Terni, Terni, Italy.
  • Fornarini G; Medical Oncology 1, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Tortora G; Medical Oncology, Fondazione Policlinico A. Gemelli IRCCS, Largo Agostino Gemelli 8, 00168 Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.
  • Iacovelli R; Medical Oncology, Fondazione Policlinico A. Gemelli IRCCS, Largo Agostino Gemelli 8, 00168 Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.
Cancer Treat Rev ; 124: 102698, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38359590
ABSTRACT
In the last years, theranostics has expanded the therapeutic options available for prostate cancer patients. In this review, we explore this dynamic field and its potential to revolutionize precision medicine for prostate cancer. We delve into the foundational principles, clinical applications, and emerging opportunities, emphasizing the potential synergy between radioligand therapy and other systemic treatments. Additionally, we address the ongoing challenges, including optimizing patient selection, assessing treatment responses, and determining the role of theranostics within the broader landscape of prostate cancer treatment.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Medicina de Precisão Limite: Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Medicina de Precisão Limite: Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article